HSD17B13 and metabolic dysfunction-associated steatotic liver disease: Additionally, while we analyzed the main ApoC-III variants, we did not investigate other SNPs such as PNPLA3, TM6SF2, GCKR, MBOAT7, or HSD17B13, which are extensively recognized for their significant contributions to MASLD susceptibility and progression.